Sintilimab plus Anlotinib and Chemotherapy as First-line Treatment for Advanced Malignant Pleural Mesothelioma (SACH-MPM): A Prospective, Single-arm, Phase II Trial
Fuente:
Zenodo
Saved in:
| Main Author: | |
|---|---|
| Format: | Recurso digital |
| Published: |
Zenodo
2026
|
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1866901738469982208 |
|---|---|
| author | Huang, Yiyi |
| author_facet | Huang, Yiyi |
| contents | |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_20200303 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Sintilimab plus Anlotinib and Chemotherapy as First-line Treatment for Advanced Malignant Pleural Mesothelioma (SACH-MPM): A Prospective, Single-arm, Phase II Trial Huang, Yiyi |
| title | Sintilimab plus Anlotinib and Chemotherapy as First-line Treatment for Advanced Malignant Pleural Mesothelioma (SACH-MPM): A Prospective, Single-arm, Phase II Trial |
| url | https://doi.org/10.5281/zenodo.20200303 |